Ra Medical Systems, Inc.
RMED · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.07 | 0.00 | -0.00 |
| FCF Yield | -58.64% | 0.00% | -36.19% | 139.03% |
| EV / EBITDA | -3.31 | -2.10 | -2.17 | 0.02 |
| Quality | ||||
| ROIC | -13.13% | -16.53% | -13.50% | -176.88% |
| Gross Margin | 92.04% | 93.40% | 92.31% | 93.55% |
| Cash Conversion Ratio | 1.90 | – | 0.58 | 0.05 |
| Growth | ||||
| Revenue 3-Year CAGR | 86.44% | 168.83% | 181.76% | 159.83% |
| Free Cash Flow Growth | 0.00% | 100.00% | -190.00% | 206.40% |
| Safety | ||||
| Net Debt / EBITDA | -0.80 | -0.46 | -0.35 | -0.02 |
| Interest Coverage | 86.31 | -69.73 | -72.73 | 526.45 |
| Efficiency | ||||
| Inventory Turnover | 0.53 | 0.29 | 0.15 | 0.18 |
| Cash Conversion Cycle | -5,176.02 | -4,811.18 | -4,659.23 | -2,887.26 |